Next generation protein interrogation powered by nanoneedles, enabling early disease detection, prognostic monitoring and biomarker discovery on a single chip.
Location: United States, Massachusetts, Woburn
Employees: 11-50
Total raised: $40.75M
Investors 2
| Date | Name | Website |
| 08.12.2021 | RA Capital... | racap.com |
| 19.04.2022 | Insight Pa... | insightpar... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.12.2021 | Series A | $40.75M | - |
Mentions in press and media 3
| Date | Title | Description |
| 06.12.2021 | NanoMosaic Closes $40.75M Series A Funding Round | NanoMosaic Inc., a Boston, MA-based pioneer and leader in nanoneedle detection for proteomics and multi-omics applications, closed a $40.75m Series A financing. The round was led by RA Capital Management, joined by Insight Partners, Pura Vi... |
| 16.12.2020 | NanoMosaic Announces Beta Placement of its Tessie™ System at Massachusetts General Hospital to Run Clinical Samples | |
| - | NanoMosaic | “Interrogate and understand protein, nucleic acid & other interactions at a nano scale. All in a workflow that’s easy and familiar.” |